Compare Citius Pharmaceuticals Inc (CTXR) vs Main Street Capital Corporation (MAIN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs Main Street Capital Corporation — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while Main Street Capital Corporation trades at $59 (market cap $5.52B). The key difference: Main Street Capital Corporation is far larger — about 275.9× Citius Pharmaceuticals Inc's market cap, and Main Street Capital Corporation pays a 5.39% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| CTXR | MAIN | |
|---|---|---|
Market Cap | $20.01M | $5.52B |
Sector | Health | Financials |
52-Week High | $1.82 | $67.54 |
52-Week Low | $0.48 | $49.63 |
Enterprise Value | $16.23M | — |
Dividend Yield | — | 5.39% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About Main Street Capital Corporation
Main Street Capital Corp is an investment firm engaged in providing customized debt and equity financing to lower middle market companies and debt capital to middle market companies. The investment portfolio of the company is typically made to support management buyouts, recapitalizations, growth financings, refinancings and acquisitions of companies that operate in diverse industry sectors. The group invests in secured debt investments, equity investments, warrants and other securities of the lower middle market and middle market companies based in the US. Business is functioned through the U.S region and it derives the majority of the income from the source of fee, commission, and interest.
Read more on MAIN →
